5.700USD-4.36%Mkt Cap: 64.29M USDP/E: —Last update: 2026-06-01
ImageneBio, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for patients with immunological, autoimmune and inflammatory diseases. Its lead product candidate includes IMG-007, a non-depleting anti…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap64.29M USD
Enterprise Value-48.47M USD
Revenue (TTM)0 USD
Gross Profit0 USD
Net Income (TTM)-45.35M USD
Revenue/Share0.0000 USD
Last Price5.700 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees17
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.48
PEG—
EV/EBITDA0.90
EV/Revenue—
P/SInfinity
P/B0.54
EPS (TTM)-4.78
EPS (Forward)-3.98
52W Range
3.94013% of range18.00
52W High18.00 USD
52W Low3.940 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin-5668.63%
ROE-34.06%
ROA-29.64%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-47.84M USD
CapEx (TTM)—
FCF Margin—
FCF Yield-42.41%
Net Debt-114.79M USD
Net Debt/EBITDA2.12
Balance Sheet
Debt/Equity0.02
Current Ratio18.39
Quick Ratio17.67
Book Value/Sh10.93 USD
Cash/Share10.39 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:12
Split DateJul 28, 2025
Analyst Consensus
Rating—
Target (Mean)24.00 USD
Target Range24.00 USD – 24.00 USD
# Analysts1
Ownership
Shares Out.11.28M
Float5.80M
Insiders14.96%
Institutions55.47%
Short Interest
Short Ratio6.1d
Short % Float4.01%
Short % Out.3.95%
Shares Short445.01K
Short (prev mo.)587.28K
Technical
SMA 505.560 (+2.5%)
SMA 2007.392 (-22.9%)
Beta—
S&P 52W Chg27.94%
Avg Vol (30d)49.19K
Avg Vol (10d)15.95K
Technical Indicators
RSI (14)55.5
MACD0.0320
MACD Signal-0.0010
MACD Hist.+0.0330
BB Upper6.151 USD
BB Middle5.706 USD
BB Lower5.260 USD
BB Width15.61%
ATR (14)0.3868 USD
Vol Ratio (20d)0.17x